Minerva Neurosciences
$5.319876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$5.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.38 (-6.68%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell NERV and other stocks, options, ETFs, and crypto commission-free!
About NERV
Minerva Neurosciences, Inc Common Stock, also called Minerva Neurosciences, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product pipeline includes Roluperidone, Seltorexant, MIN-117, and MIN-301. Read More The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.
Employees
13
Headquarters
Waltham, Massachusetts
Founded
2007
Market Cap
219.23M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
342.28K
High Today
$5.74
Low Today
$5.17
Open Price
$5.61
Volume
472.89K
52 Week High
$9.56
52 Week Low
$2.00
Collections
NERV Earnings
-$0.77
-$0.51
-$0.26
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 4, Pre-Market